Skip to main content

Table 6 Multivariate analysis for estimating factors associated with a 3-month response after intravitreal injection of ranibizumab

From: Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration

Variables

P value*

OR (95 % CI)

Sex (male)

0.511

1.879 (0.287–12.306)

Age (years)

0.602

1.038 (0.903–1.193)

Decreased proportion of subfoveal CT

0.042

1.362 (1.016–1.825)

Decreased proportion of mean temporal peripapillary CT

0.166

0.861 (0.696–1.064)

  1. *P value based on logistic regression analysis
  2. CT choroidal thickness